Research Site

Split 21000

1 studies enrolling now · 6 studies all time

What they study most

Asthma, Breast Cancer, Early Breast Cancer, Lupus Erythematosus, Systemic, Non-Small-Cell Lung Carcinoma, Relapsing-Remitting Multiple Sclerosis, Type 2 Diabetes

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma — Completed
• CLARITY Extension Study — Completed
• Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) — Completed
• Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment — Completed
• Iressa Versus Docetaxel (Taxotere) — Completed